Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria
Authors:
- Yanyan PanYPYanyan Pan
- Ying LiYLYing Li
- Yongjun JiangYJYongjun Jiang
- Hong ShangHSHong Shang
- D. Channe GowdaDGD. Channe Gowda
- Liwang CuiLCLiwang Cui
- Yaming CaoYCYaming Cao
- 1 August 2012
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 13 (4) , 392-397
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malariaProceedings of the National Academy of Sciences, 2011
- Protein–DNA Complex Is the Exclusive Malaria Parasite Component That Activates Dendritic Cells and Triggers Innate Immune ResponsesThe Journal of Immunology, 2010
- Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and functionProceedings of the National Academy of Sciences, 2009
- Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2008
- Cooperation of Toll-like receptor signals in innate immune defenceNature Reviews Immunology, 2007
- Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9Proceedings of the National Academy of Sciences, 2007
- Dendritic cells in a mature ageNature Reviews Immunology, 2006
- Immunological processes in malaria pathogenesisNature Reviews Immunology, 2005
- Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent mannerEuropean Journal of Immunology, 2004
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001